COc1ccc2[nH]c3c(c2c1)CCN1C(=O)C(CC(=O)NCC24C[C@H]5C[C@@H](C2)C[C@@H](C4)C5)C[C@H](C(=O)N2CCCCC2)[C@@]31C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?